Ology Bio’s Process Development Group can develop an entire process or optimize individual steps in an existing process to ensure the process is suitable for manufacturing in a CGMP environment.
We can screen production strains to select a cell line that will efficiently provide the best possible expression of your drug substance. We develop processes to take advantage of methods, such as high cell density fermentation, to increase product yield and manufacture the best quality product in the most efficient way possible.
In creating a manufacturing process suitable for CGMP production, our process scientists take a modular, Design of Experiment (DOE) based approach to develop optimal fermentation and product recovery processes, as well as downstream purification steps. The Process Development group works hand-in-hand with our Analytical Group to ensure the integrity of your molecule each step of the way. Technology transfer of an existing process from the Process Development Group to the CGMP Manufacturing Group will support an integrated approach of the manufacturing process into the CGMP manufacturing facility.